National Cancer Institute
Cancer Imaging Program
Print Friendly Version | Text Only | Contact Us  
Home
About CIP
Research Funding
 
Current Funding Opportunities
 
Past Funding Opportunities
 
Mechanisms
 
Application Guidelines
 
Career Training and Education
Programs & Resources
Clinical Trials
Reports & Publications
News & Meetings
Imaging Information
Imaging Guidelines
Research Funding
RFA: CA-99-015 / PAR-99-149 (SBIR/STTR): Diagnostic Imaging and Guided Therapy in Prostate Cancer. Phased Innovation Award (R21/R33)

Grants are designed to support the development, risk assessment, and application of improved imaging methods for the localization, biopsy and image guided biopsy or therapy of prostate cancer. Relevant investigations could include technology development, in vitro laboratory work, pre-clinical animal studies, or early feasibility testing in humans depending on the maturity of the methods proposed, or evaluation of the effects of age-associated changes and co-morbid conditions as they affect imaging diagnosis and treatment techniques.

  • Letter of Intent : National Cancer Institute and National Institute on Aging Receipt Date: October 20, 1999.
  • Application Receipt Date(s): November 17, 1999.
  • $1.6M FY 2000/ $13.6M Total
  • Contact: Barbara Y. Croft, Ph.D. (bc129b@nih.gov) at 301-496-9531

See full description in NIH Guide: RFA: CA-99-015

See full description in NIH Guide: PAR-99-149 (SBIR/STTR)

National Cancer InstituteDepartment of Health & Human ServicesNational Institutes of HealthFirstGov.gov